- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02636153
the Effects of Different Dietary Phosphorus Intake on the Circadian Pattern of Serum Phosphate in Normal Subjects
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Emerging evidence show that serum phosphate concentrations are not only associated with cardiovascular and all-cause mortality in chronic kidney disease (CKD) patients, but also associated with the mortality in community population (without history of CKD or cardiovascular disease). The rise of serum phosphate will lead to the elevation of serum plasma fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) in healthy people, contributing to bone disorders and left ventricle thickening. Therefore, maintaining normal serum phosphate and reducing postprandial fluctuation of serum phosphate are essential for CKD patients as well as healthy people.
As for serum phosphate modulation by diet, most evidence was focused on CKD patients, less focused on healthy people. An American study in 1980s indicated that phosphorus intake was significantly related with the level of 24-h serum phosphate and the circadian pattern of serum phosphate. However, this study failed to explore the underlying mechanisms and the diet in America is different from that in China. Nowadays, normal diet in China is inclined to having more calories and protein, which warrants high diet phosphorus intake, may contributing to huge fluctuation of serum phosphate and thus elevating the incidence and mortality of cardiovascular disease. Therefore, what is the level and circadian pattern of serum phosphate concentrations in normal subjects under our native normal diet in China? Is restricted phosphate diet able to alter the level and circadian pattern of serum phosphate? These questions are what the investigator sare eager to answer.
Accumulating evidence suggest that gastrointestinal tract has a vital effect in phosphate modulation. Berndt etc. suggested that in rat, epidermal cells of duodenum and jejunum could sense the gastrointestinal tract phosphate load, rapidly activating the type IIa Na/Pi-cotransporter in the renal tubule cells, leading to the increase of urinary phosphate, without any changes of serum FGF23, PTH and phosphate concentrations. So the author proposed that there had a gastro intestine-kidney axis in phosphate modulation. However, whether this axis exists in human body remains unclear.
Therefore, the investigators plan to conduct a crossover clinical study to evaluate the level and circadian pattern of serum phosphate concentrations modulated by native normal diet and restricted phosphate diet and then to explore the underlying mechanisms.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Shanghai
-
Shanghai, Shanghai, Porcelana, 200040
- Huashan hospital, Shanghai Medical College, Fudan University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Men aged 18-45 years
- Healthy volunteers: no history of chronic diseases; no active symptoms or physical signs; negative results of electrocardiogram and chest X-ray; biochemical indicators of regular medical examination are within 95%-105% of normal range
- Willingness to sign the consent form approved by an Institutional Review Board and comply with the study protocol
- Body mass index ranged within 18.5-24 kg/m2
Exclusion Criteria:
- Current history of drug or alcohol abuse as assessed by the principal Investigator
- Subject has blood donations or blood loss more than 300ml within three months
- Allergic to more than two foods or drugs
- Subject has psycho-disability or body disability
- Subject has a condition that in the judgment of the Principal Investigator could potentially pose a health risk to the patient while involved in the study
- Subject has participated in the other clinical trials at the same time
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Dieta normal de fósforo
Dieta que contiene 1500 mg de fósforo por día.
|
Dieta que contiene 1500 mg de fósforo
|
Experimental: Restricted Phosphorus Diet
Diet containing 500mg of phosphorus per day
|
Diet containing 500mg of phosphorus
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
---|---|
Ritmo circadiano de la concentración sérica de fósforo
Periodo de tiempo: 24 horas
|
24 horas
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
---|---|
Ritmo circadiano del factor de crecimiento de fibroblastos plasmáticos 23 (FGF23)
Periodo de tiempo: 24 horas
|
24 horas
|
Ritmo circadiano de la hormona paratiroidea (PTH)
Periodo de tiempo: 24 horas
|
24 horas
|
Ritmo circadiano de 1, 25-dihidroxivitamina D (1,25(OH)2D3)
Periodo de tiempo: 24 horas
|
24 horas
|
Circadian rhythm of matrix extracellular phosphoglycoprotein (MEPE)
Periodo de tiempo: 24 hour
|
24 hour
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- HuashanH
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre dieta normal
-
Mondelēz International, Inc.KGK Science Inc.Terminado
-
University of CalgaryStewart Diabetes Education FundTerminadoObesidad | Diabetes mellitus tipo 2Canadá
-
Vegenat, S.A.DesconocidoEnfermedad de Parkinson | Enfermedad de alzheimer | Demencia senilEspaña
-
Vegenat, S.A.DesconocidoNutrición enteral | Pancreatitis agudaEspaña
-
Helsinki University Central HospitalLaerdal Foundation; The Finnish Medical Association; Orion Research Foundation; Finnish...TerminadoParo cardíaco fuera del hospitalDinamarca, Finlandia
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)TerminadoObesidad | Enfermedad cardiovascular | Diabetes Mellitus, Tipo IIEstados Unidos
-
Texas Cardiac Arrhythmia Research FoundationSuspendidoArritmia ventricularEstados Unidos
-
Ann & Robert H Lurie Children's Hospital of ChicagoRetirado
-
Texas Cardiac Arrhythmia Research FoundationTerminadoFibrilación auricularCanadá, Estados Unidos
-
MemorialCare Health SystemTerminadoDuración del trabajo de parto | Segunda etapa del trabajo de parto | Hidratación intravenosa del partoEstados Unidos